Efficacy and Safety of Dapagliflozin as Adjunct Therapy in Patients with Type 2 Diabetes Mellitus Inadequately Controlled on Metformin and Sulfonylurea. Academia Journal of Medicine, [S. l.], v. 9, n. 2, p. 201–205, 2026. DOI: 10.48165/ajm.2026.9.02.34. Disponível em: https://medjournal.co.in/index.php/ajm/article/view/358. Acesso em: 25 oct. 2026.